13D

Company

TENAX THERAPEUTICS, INC.

Filed

May 18, 2020

Accession Number

0001783976-20-000008

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →